0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Model Species Market Research Report 2024
Published Date: April 2024
|
Report Code: QYRE-Auto-28R14645
Home | Market Reports | Health| Nursing
Global Model Species Market Insights Forecast to 2029
BUY CHAPTERS

Global Model Species Market Research Report 2024

Code: QYRE-Auto-28R14645
Report
April 2024
Pages:95
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Model Species Market

The global Model Species market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Model Species is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Model Species is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Model Species in Drug Discovery is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Model Species include Shanghai Model Organisms Center, Inc., Gem Pharmatech Co., Ltd., Charles River Laboratories, Envigo, Taconic Biosciences, Jackson Laboratory, Shanghai SLAC, Joinn Laboratories and Crown Biosciences, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Model Species, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Model Species.

Model Species Market Major Factors

The model species market benefits from expanding research in genetics, drug discovery, and disease modeling. Model organisms like zebrafish, mice, and fruit flies continue to serve as essential tools in biomedical research due to their genetic similarity to humans and short reproduction cycles. The integration of CRISPR and other gene-editing techniques accelerates experimental timelines and enhances data accuracy. Pharmaceutical and academic institutions invest in maintaining standardized colonies and digital record systems for reproducibility. The increasing prevalence of chronic diseases and demand for translational research boost the global market’s relevance across life sciences.

Model Species Market Trends

Integration of AI in model species research enables automated image analysis and behavior tracking, improving experimental precision. Machine learning algorithms assist in phenotype recognition, significantly reducing manual error and accelerating insights into gene-function relationships.

Ethical and sustainable sourcing practices are gaining prominence. Researchers focus on reducing animal use through organ-on-chip and in-silico modeling while retaining model species as validation tools.

Collaborative research networks are expanding globally, encouraging data sharing and cross-laboratory standardization. Cloud databases and open-source genetic platforms enhance reproducibility and transparency across scientific communities.

Model Species Market Share

North America remains the primary hub for model species research, driven by well-funded academic and pharmaceutical sectors. Europe sustains steady demand through biotechnology clusters and collaborative research frameworks. Asia-Pacific is witnessing rapid growth due to expanding life science research investments in China, Japan, and India. Latin America and the Middle East are gradually building infrastructure for preclinical testing and academic research, contributing to a diversified and collaborative global market landscape.
 
Market Segmentation

Scope of Model Species Market Report

Report Metric Details
Report Name Model Species Market
Segment by Type
  • Rat
  • Mouse
  • Zebrafish
  • Arabidopsis Thaliana
  • Others
Segment by Application
  • Drug Discovery
  • Basic Research
  • Toxicity Test
  • Parasitological Study
  • Hereditary Disease Study
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Shanghai Model Organisms Center, Inc., Gem Pharmatech Co., Ltd., Charles River Laboratories, Envigo, Taconic Biosciences, Jackson Laboratory, Shanghai SLAC, Joinn Laboratories, Crown Biosciences, Pharmalegacy, Syngene International, Janvier Labs, GenOway, Psychogenics, Horizon Discovery Group, Vitalstar Biotechnology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Model Species companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Model Species Market report?

Ans: The main players in the Model Species Market are Shanghai Model Organisms Center, Inc., Gem Pharmatech Co., Ltd., Charles River Laboratories, Envigo, Taconic Biosciences, Jackson Laboratory, Shanghai SLAC, Joinn Laboratories, Crown Biosciences, Pharmalegacy, Syngene International, Janvier Labs, GenOway, Psychogenics, Horizon Discovery Group, Vitalstar Biotechnology

What are the Application segmentation covered in the Model Species Market report?

Ans: The Applications covered in the Model Species Market report are Drug Discovery, Basic Research, Toxicity Test, Parasitological Study, Hereditary Disease Study

What are the Type segmentation covered in the Model Species Market report?

Ans: The Types covered in the Model Species Market report are Rat, Mouse, Zebrafish, Arabidopsis Thaliana, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Model Species Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Rat
1.2.3 Mouse
1.2.4 Zebrafish
1.2.5 Arabidopsis Thaliana
1.2.6 Others
1.3 Market by Application
1.3.1 Global Model Species Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Drug Discovery
1.3.3 Basic Research
1.3.4 Toxicity Test
1.3.5 Parasitological Study
1.3.6 Hereditary Disease Study
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Model Species Market Perspective (2019-2030)
2.2 Model Species Growth Trends by Region
2.2.1 Global Model Species Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Model Species Historic Market Size by Region (2019-2024)
2.2.3 Model Species Forecasted Market Size by Region (2025-2030)
2.3 Model Species Market Dynamics
2.3.1 Model Species Industry Trends
2.3.2 Model Species Market Drivers
2.3.3 Model Species Market Challenges
2.3.4 Model Species Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Model Species Players by Revenue
3.1.1 Global Top Model Species Players by Revenue (2019-2024)
3.1.2 Global Model Species Revenue Market Share by Players (2019-2024)
3.2 Global Model Species Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Model Species Revenue
3.4 Global Model Species Market Concentration Ratio
3.4.1 Global Model Species Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Model Species Revenue in 2023
3.5 Model Species Key Players Head office and Area Served
3.6 Key Players Model Species Product Solution and Service
3.7 Date of Enter into Model Species Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Model Species Breakdown Data by Type
4.1 Global Model Species Historic Market Size by Type (2019-2024)
4.2 Global Model Species Forecasted Market Size by Type (2025-2030)
5 Model Species Breakdown Data by Application
5.1 Global Model Species Historic Market Size by Application (2019-2024)
5.2 Global Model Species Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Model Species Market Size (2019-2030)
6.2 North America Model Species Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Model Species Market Size by Country (2019-2024)
6.4 North America Model Species Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Model Species Market Size (2019-2030)
7.2 Europe Model Species Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Model Species Market Size by Country (2019-2024)
7.4 Europe Model Species Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Model Species Market Size (2019-2030)
8.2 Asia-Pacific Model Species Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Model Species Market Size by Region (2019-2024)
8.4 Asia-Pacific Model Species Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Model Species Market Size (2019-2030)
9.2 Latin America Model Species Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Model Species Market Size by Country (2019-2024)
9.4 Latin America Model Species Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Model Species Market Size (2019-2030)
10.2 Middle East & Africa Model Species Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Model Species Market Size by Country (2019-2024)
10.4 Middle East & Africa Model Species Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Shanghai Model Organisms Center, Inc.
11.1.1 Shanghai Model Organisms Center, Inc. Company Detail
11.1.2 Shanghai Model Organisms Center, Inc. Business Overview
11.1.3 Shanghai Model Organisms Center, Inc. Model Species Introduction
11.1.4 Shanghai Model Organisms Center, Inc. Revenue in Model Species Business (2019-2024)
11.1.5 Shanghai Model Organisms Center, Inc. Recent Development
11.2 Gem Pharmatech Co., Ltd.
11.2.1 Gem Pharmatech Co., Ltd. Company Detail
11.2.2 Gem Pharmatech Co., Ltd. Business Overview
11.2.3 Gem Pharmatech Co., Ltd. Model Species Introduction
11.2.4 Gem Pharmatech Co., Ltd. Revenue in Model Species Business (2019-2024)
11.2.5 Gem Pharmatech Co., Ltd. Recent Development
11.3 Charles River Laboratories
11.3.1 Charles River Laboratories Company Detail
11.3.2 Charles River Laboratories Business Overview
11.3.3 Charles River Laboratories Model Species Introduction
11.3.4 Charles River Laboratories Revenue in Model Species Business (2019-2024)
11.3.5 Charles River Laboratories Recent Development
11.4 Envigo
11.4.1 Envigo Company Detail
11.4.2 Envigo Business Overview
11.4.3 Envigo Model Species Introduction
11.4.4 Envigo Revenue in Model Species Business (2019-2024)
11.4.5 Envigo Recent Development
11.5 Taconic Biosciences
11.5.1 Taconic Biosciences Company Detail
11.5.2 Taconic Biosciences Business Overview
11.5.3 Taconic Biosciences Model Species Introduction
11.5.4 Taconic Biosciences Revenue in Model Species Business (2019-2024)
11.5.5 Taconic Biosciences Recent Development
11.6 Jackson Laboratory
11.6.1 Jackson Laboratory Company Detail
11.6.2 Jackson Laboratory Business Overview
11.6.3 Jackson Laboratory Model Species Introduction
11.6.4 Jackson Laboratory Revenue in Model Species Business (2019-2024)
11.6.5 Jackson Laboratory Recent Development
11.7 Shanghai SLAC
11.7.1 Shanghai SLAC Company Detail
11.7.2 Shanghai SLAC Business Overview
11.7.3 Shanghai SLAC Model Species Introduction
11.7.4 Shanghai SLAC Revenue in Model Species Business (2019-2024)
11.7.5 Shanghai SLAC Recent Development
11.8 Joinn Laboratories
11.8.1 Joinn Laboratories Company Detail
11.8.2 Joinn Laboratories Business Overview
11.8.3 Joinn Laboratories Model Species Introduction
11.8.4 Joinn Laboratories Revenue in Model Species Business (2019-2024)
11.8.5 Joinn Laboratories Recent Development
11.9 Crown Biosciences
11.9.1 Crown Biosciences Company Detail
11.9.2 Crown Biosciences Business Overview
11.9.3 Crown Biosciences Model Species Introduction
11.9.4 Crown Biosciences Revenue in Model Species Business (2019-2024)
11.9.5 Crown Biosciences Recent Development
11.10 Pharmalegacy
11.10.1 Pharmalegacy Company Detail
11.10.2 Pharmalegacy Business Overview
11.10.3 Pharmalegacy Model Species Introduction
11.10.4 Pharmalegacy Revenue in Model Species Business (2019-2024)
11.10.5 Pharmalegacy Recent Development
11.11 Syngene International
11.11.1 Syngene International Company Detail
11.11.2 Syngene International Business Overview
11.11.3 Syngene International Model Species Introduction
11.11.4 Syngene International Revenue in Model Species Business (2019-2024)
11.11.5 Syngene International Recent Development
11.12 Janvier Labs
11.12.1 Janvier Labs Company Detail
11.12.2 Janvier Labs Business Overview
11.12.3 Janvier Labs Model Species Introduction
11.12.4 Janvier Labs Revenue in Model Species Business (2019-2024)
11.12.5 Janvier Labs Recent Development
11.13 GenOway
11.13.1 GenOway Company Detail
11.13.2 GenOway Business Overview
11.13.3 GenOway Model Species Introduction
11.13.4 GenOway Revenue in Model Species Business (2019-2024)
11.13.5 GenOway Recent Development
11.14 Psychogenics
11.14.1 Psychogenics Company Detail
11.14.2 Psychogenics Business Overview
11.14.3 Psychogenics Model Species Introduction
11.14.4 Psychogenics Revenue in Model Species Business (2019-2024)
11.14.5 Psychogenics Recent Development
11.15 Horizon Discovery Group
11.15.1 Horizon Discovery Group Company Detail
11.15.2 Horizon Discovery Group Business Overview
11.15.3 Horizon Discovery Group Model Species Introduction
11.15.4 Horizon Discovery Group Revenue in Model Species Business (2019-2024)
11.15.5 Horizon Discovery Group Recent Development
11.16 Vitalstar Biotechnology
11.16.1 Vitalstar Biotechnology Company Detail
11.16.2 Vitalstar Biotechnology Business Overview
11.16.3 Vitalstar Biotechnology Model Species Introduction
11.16.4 Vitalstar Biotechnology Revenue in Model Species Business (2019-2024)
11.16.5 Vitalstar Biotechnology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Model Species Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Rat
    Table 3. Key Players of Mouse
    Table 4. Key Players of Zebrafish
    Table 5. Key Players of Arabidopsis Thaliana
    Table 6. Key Players of Others
    Table 7. Global Model Species Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Model Species Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 9. Global Model Species Market Size by Region (2019-2024) & (US$ Million)
    Table 10. Global Model Species Market Share by Region (2019-2024)
    Table 11. Global Model Species Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 12. Global Model Species Market Share by Region (2025-2030)
    Table 13. Model Species Market Trends
    Table 14. Model Species Market Drivers
    Table 15. Model Species Market Challenges
    Table 16. Model Species Market Restraints
    Table 17. Global Model Species Revenue by Players (2019-2024) & (US$ Million)
    Table 18. Global Model Species Market Share by Players (2019-2024)
    Table 19. Global Top Model Species Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Model Species as of 2023)
    Table 20. Ranking of Global Top Model Species Companies by Revenue (US$ Million) in 2023
    Table 21. Global 5 Largest Players Market Share by Model Species Revenue (CR5 and HHI) & (2019-2024)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Model Species Product Solution and Service
    Table 24. Date of Enter into Model Species Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Model Species Market Size by Type (2019-2024) & (US$ Million)
    Table 27. Global Model Species Revenue Market Share by Type (2019-2024)
    Table 28. Global Model Species Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 29. Global Model Species Revenue Market Share by Type (2025-2030)
    Table 30. Global Model Species Market Size by Application (2019-2024) & (US$ Million)
    Table 31. Global Model Species Revenue Market Share by Application (2019-2024)
    Table 32. Global Model Species Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 33. Global Model Species Revenue Market Share by Application (2025-2030)
    Table 34. North America Model Species Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 35. North America Model Species Market Size by Country (2019-2024) & (US$ Million)
    Table 36. North America Model Species Market Size by Country (2025-2030) & (US$ Million)
    Table 37. Europe Model Species Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 38. Europe Model Species Market Size by Country (2019-2024) & (US$ Million)
    Table 39. Europe Model Species Market Size by Country (2025-2030) & (US$ Million)
    Table 40. Asia-Pacific Model Species Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 41. Asia-Pacific Model Species Market Size by Region (2019-2024) & (US$ Million)
    Table 42. Asia-Pacific Model Species Market Size by Region (2025-2030) & (US$ Million)
    Table 43. Latin America Model Species Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Latin America Model Species Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Latin America Model Species Market Size by Country (2025-2030) & (US$ Million)
    Table 46. Middle East & Africa Model Species Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 47. Middle East & Africa Model Species Market Size by Country (2019-2024) & (US$ Million)
    Table 48. Middle East & Africa Model Species Market Size by Country (2025-2030) & (US$ Million)
    Table 49. Shanghai Model Organisms Center, Inc. Company Detail
    Table 50. Shanghai Model Organisms Center, Inc. Business Overview
    Table 51. Shanghai Model Organisms Center, Inc. Model Species Product
    Table 52. Shanghai Model Organisms Center, Inc. Revenue in Model Species Business (2019-2024) & (US$ Million)
    Table 53. Shanghai Model Organisms Center, Inc. Recent Development
    Table 54. Gem Pharmatech Co., Ltd. Company Detail
    Table 55. Gem Pharmatech Co., Ltd. Business Overview
    Table 56. Gem Pharmatech Co., Ltd. Model Species Product
    Table 57. Gem Pharmatech Co., Ltd. Revenue in Model Species Business (2019-2024) & (US$ Million)
    Table 58. Gem Pharmatech Co., Ltd. Recent Development
    Table 59. Charles River Laboratories Company Detail
    Table 60. Charles River Laboratories Business Overview
    Table 61. Charles River Laboratories Model Species Product
    Table 62. Charles River Laboratories Revenue in Model Species Business (2019-2024) & (US$ Million)
    Table 63. Charles River Laboratories Recent Development
    Table 64. Envigo Company Detail
    Table 65. Envigo Business Overview
    Table 66. Envigo Model Species Product
    Table 67. Envigo Revenue in Model Species Business (2019-2024) & (US$ Million)
    Table 68. Envigo Recent Development
    Table 69. Taconic Biosciences Company Detail
    Table 70. Taconic Biosciences Business Overview
    Table 71. Taconic Biosciences Model Species Product
    Table 72. Taconic Biosciences Revenue in Model Species Business (2019-2024) & (US$ Million)
    Table 73. Taconic Biosciences Recent Development
    Table 74. Jackson Laboratory Company Detail
    Table 75. Jackson Laboratory Business Overview
    Table 76. Jackson Laboratory Model Species Product
    Table 77. Jackson Laboratory Revenue in Model Species Business (2019-2024) & (US$ Million)
    Table 78. Jackson Laboratory Recent Development
    Table 79. Shanghai SLAC Company Detail
    Table 80. Shanghai SLAC Business Overview
    Table 81. Shanghai SLAC Model Species Product
    Table 82. Shanghai SLAC Revenue in Model Species Business (2019-2024) & (US$ Million)
    Table 83. Shanghai SLAC Recent Development
    Table 84. Joinn Laboratories Company Detail
    Table 85. Joinn Laboratories Business Overview
    Table 86. Joinn Laboratories Model Species Product
    Table 87. Joinn Laboratories Revenue in Model Species Business (2019-2024) & (US$ Million)
    Table 88. Joinn Laboratories Recent Development
    Table 89. Crown Biosciences Company Detail
    Table 90. Crown Biosciences Business Overview
    Table 91. Crown Biosciences Model Species Product
    Table 92. Crown Biosciences Revenue in Model Species Business (2019-2024) & (US$ Million)
    Table 93. Crown Biosciences Recent Development
    Table 94. Pharmalegacy Company Detail
    Table 95. Pharmalegacy Business Overview
    Table 96. Pharmalegacy Model Species Product
    Table 97. Pharmalegacy Revenue in Model Species Business (2019-2024) & (US$ Million)
    Table 98. Pharmalegacy Recent Development
    Table 99. Syngene International Company Detail
    Table 100. Syngene International Business Overview
    Table 101. Syngene International Model Species Product
    Table 102. Syngene International Revenue in Model Species Business (2019-2024) & (US$ Million)
    Table 103. Syngene International Recent Development
    Table 104. Janvier Labs Company Detail
    Table 105. Janvier Labs Business Overview
    Table 106. Janvier Labs Model Species Product
    Table 107. Janvier Labs Revenue in Model Species Business (2019-2024) & (US$ Million)
    Table 108. Janvier Labs Recent Development
    Table 109. GenOway Company Detail
    Table 110. GenOway Business Overview
    Table 111. GenOway Model Species Product
    Table 112. GenOway Revenue in Model Species Business (2019-2024) & (US$ Million)
    Table 113. GenOway Recent Development
    Table 114. Psychogenics Company Detail
    Table 115. Psychogenics Business Overview
    Table 116. Psychogenics Model Species Product
    Table 117. Psychogenics Revenue in Model Species Business (2019-2024) & (US$ Million)
    Table 118. Psychogenics Recent Development
    Table 119. Horizon Discovery Group Company Detail
    Table 120. Horizon Discovery Group Business Overview
    Table 121. Horizon Discovery Group Model Species Product
    Table 122. Horizon Discovery Group Revenue in Model Species Business (2019-2024) & (US$ Million)
    Table 123. Horizon Discovery Group Recent Development
    Table 124. Vitalstar Biotechnology Company Detail
    Table 125. Vitalstar Biotechnology Business Overview
    Table 126. Vitalstar Biotechnology Model Species Product
    Table 127. Vitalstar Biotechnology Revenue in Model Species Business (2019-2024) & (US$ Million)
    Table 128. Vitalstar Biotechnology Recent Development
    Table 129. Research Programs/Design for This Report
    Table 130. Key Data Information from Secondary Sources
    Table 131. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Model Species Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Model Species Market Share by Type: 2023 VS 2030
    Figure 3. Rat Features
    Figure 4. Mouse Features
    Figure 5. Zebrafish Features
    Figure 6. Arabidopsis Thaliana Features
    Figure 7. Others Features
    Figure 8. Global Model Species Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 9. Global Model Species Market Share by Application: 2023 VS 2030
    Figure 10. Drug Discovery Case Studies
    Figure 11. Basic Research Case Studies
    Figure 12. Toxicity Test Case Studies
    Figure 13. Parasitological Study Case Studies
    Figure 14. Hereditary Disease Study Case Studies
    Figure 15. Model Species Report Years Considered
    Figure 16. Global Model Species Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 17. Global Model Species Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 18. Global Model Species Market Share by Region: 2023 VS 2030
    Figure 19. Global Model Species Market Share by Players in 2023
    Figure 20. Global Top Model Species Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Model Species as of 2023)
    Figure 21. The Top 10 and 5 Players Market Share by Model Species Revenue in 2023
    Figure 22. North America Model Species Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. North America Model Species Market Share by Country (2019-2030)
    Figure 24. United States Model Species Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Canada Model Species Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Europe Model Species Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Europe Model Species Market Share by Country (2019-2030)
    Figure 28. Germany Model Species Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. France Model Species Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. U.K. Model Species Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Italy Model Species Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Russia Model Species Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Nordic Countries Model Species Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Asia-Pacific Model Species Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Asia-Pacific Model Species Market Share by Region (2019-2030)
    Figure 36. China Model Species Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Japan Model Species Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. South Korea Model Species Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Southeast Asia Model Species Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. India Model Species Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Australia Model Species Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Latin America Model Species Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Latin America Model Species Market Share by Country (2019-2030)
    Figure 44. Mexico Model Species Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Brazil Model Species Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Middle East & Africa Model Species Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Middle East & Africa Model Species Market Share by Country (2019-2030)
    Figure 48. Turkey Model Species Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Saudi Arabia Model Species Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 50. Shanghai Model Organisms Center, Inc. Revenue Growth Rate in Model Species Business (2019-2024)
    Figure 51. Gem Pharmatech Co., Ltd. Revenue Growth Rate in Model Species Business (2019-2024)
    Figure 52. Charles River Laboratories Revenue Growth Rate in Model Species Business (2019-2024)
    Figure 53. Envigo Revenue Growth Rate in Model Species Business (2019-2024)
    Figure 54. Taconic Biosciences Revenue Growth Rate in Model Species Business (2019-2024)
    Figure 55. Jackson Laboratory Revenue Growth Rate in Model Species Business (2019-2024)
    Figure 56. Shanghai SLAC Revenue Growth Rate in Model Species Business (2019-2024)
    Figure 57. Joinn Laboratories Revenue Growth Rate in Model Species Business (2019-2024)
    Figure 58. Crown Biosciences Revenue Growth Rate in Model Species Business (2019-2024)
    Figure 59. Pharmalegacy Revenue Growth Rate in Model Species Business (2019-2024)
    Figure 60. Syngene International Revenue Growth Rate in Model Species Business (2019-2024)
    Figure 61. Janvier Labs Revenue Growth Rate in Model Species Business (2019-2024)
    Figure 62. GenOway Revenue Growth Rate in Model Species Business (2019-2024)
    Figure 63. Psychogenics Revenue Growth Rate in Model Species Business (2019-2024)
    Figure 64. Horizon Discovery Group Revenue Growth Rate in Model Species Business (2019-2024)
    Figure 65. Vitalstar Biotechnology Revenue Growth Rate in Model Species Business (2019-2024)
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

RELATED REPORTS

Global Persistent Epithelial Defect Management Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-2O19977
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Intelligent Elderly Care Equipment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E8132
Wed Sep 17 00:00:00 UTC 2025

Add to Cart

Global Radiation Monitoring Systems Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-23I7304
Tue Sep 16 00:00:00 UTC 2025

Add to Cart

Global Ophthalmology Homeopathic Products Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8T5982
Tue Sep 16 00:00:00 UTC 2025

Add to Cart